supp.fit

Sage: study protocols

12 study groups say how much Sage participants took a day. These are the doses the studies gave. They are not a recommendation.

Sage: what the research found →

Dose per serving from products

111 products in our catalogue print how much Sage a serving holds.

Most common: 100 mg to 250 mg, 34% of 111 products.

Dose per servingProducts
10 mg or less
3
10 mg to 25 mg
24
25 mg to 50 mg
17
50 mg to 100 mg
4
100 mg to 250 mg
38
250 mg to 500 mg
15
500 mg to 1 g
8
over 1 g
2

Dose per serving from research

12 study groups in 9 studies say how much Sage participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 58% of 12 study groups.

Daily doseStudy groups
250 mg to 500 mg
7
500 mg to 1 g
1
1 g to 2.5 g
1
2.5 g to 5 g
0
5 g to 10 g
0
10 g to 25 g
2
over 25 g
1

Commonly used together

6 of 12 study groups took Sage with something else, but nothing that 3 or more different studies gave.

12 study groups

Study
Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery
2006 · 300 mg dried sage leaf · Healthy young participants; age range and sex not reported
300 mg1 day30
Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery
2006 · 600 mg dried sage leaf · Healthy young participants; age range and sex not reported
600 mg1 day30
[Treatment of refractory polycystic ovary syndrome by bushen huoxue method combined with ultrasound-guided follicle aspiration]
2008 · Observation group (BSHX decoction plus MFA) · Women with refractory polycystic ovary syndrome; age not reported
20 g—20
The Acute and Chronic Cognitive Effects of a Sage Extract: A Randomized, Placebo Controlled Study in Healthy Humans
2021 · Cognivia (sage) condition · Healthy adults aged 30–60 years, women and men, without a stated diagnosed condition
400 mg29 days45
[Effect of lixu jieyu recipe in treating 75 patients with chronic fatigue syndrome]
2009 · Treated group · Patients with chronic fatigue syndrome; age and sex not reported
20 g90 days40
A Randomized, Crossover Study of the Acute Cognitive and Cerebral Blood Flow Effects of Phenolic, Nitrate and Botanical Beverages in Young, Healthy Humans
2020 · Blueberry extract beverage · Healthy adults aged 18–35 years, males and females
280 mg1 day32
A Randomized, Crossover Study of the Acute Cognitive and Cerebral Blood Flow Effects of Phenolic, Nitrate and Botanical Beverages in Young, Healthy Humans
2020 · Apple extract beverage · Healthy adults aged 18–35 years, males and females
280 mg1 day32
A Randomized, Crossover Study of the Acute Cognitive and Cerebral Blood Flow Effects of Phenolic, Nitrate and Botanical Beverages in Young, Healthy Humans
2020 · Coffee berry extract beverage · Healthy adults aged 18–35 years, males and females
280 mg1 day32
Exploring the therapeutic impact of Salvia officinalis on lipid and oxidative stress markers in patients with polycystic ovary syndrome - a randomized placebo-controlled clinical trial
2025 · S. officinalis extract group · Iranian women aged 15–40 with newly diagnosed polycystic ovary syndrome
330 mg8 weeks35
Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: a randomized double-blind placebo-controlled clinical trial
2011 · sage leaf extract group · Patients aged 56.4 ± 30.3 years with hyperlipidemia (hypercholesterolemia and/or hypertriglyceridemia)
1.5 g60 days34
Efficacy of Salvia officinalis extract on the prevention of insulin resistance in euglycemic patients with polycystic ovary syndrome: A double-blinded placebo-controlled clinical trial
2020 · S. officinalis extract group · Euglycemic patients with polycystic ovary syndrome diagnosed according to Rotterdam criteria
330 mg8 weeks—
[Clinical study on treatment of mid-advanced crescentic nephritis by qingre huoxue recipe]
2004 · Treated group · Patients with biopsy-confirmed mid-advanced crescentic nephritis
30 g90 days—